ArticleTrauma case reports2026
Osteonecrosis of femoral head after cement augmented TFNA nailing for an intertrochanteric fracture: A case report.
Article in Trauma case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Failure of fixation devices (cut through) in proximal femoral fractures continues to be a concern in severe osteoporosis. Bone cement augmentation using TFNA (Trochanteric Femoral Nail-Advanced™; DePuy Synthes) increases the bone implant interphase and thereby the biomechanical stability, offering better resistance to avoid cut through. Cement augmentation does not improve implant positioning or reduction but only provides mechanical advantage to the osteoporotic bone and was reported as a safer technique in literature. Most commonly reported complication following cement augmented TFN-A insertion is cement leakage through the fracture. While ONFH (Osteonecrosis of Femoral Head) following Intertrochanteric fractures is not an uncommon complication, its incidence in AO 31A3.3 fracture pattern is very rare. An in vitro study demonstrated that there was a transient increase in intraosseous pressure with injection of 6 ml of bone cement, yet posing a very low risk of developing ONFH. Despite appropriate primary fixation for an AO 31 A3.3 fracture using a TFN-A, we observed ONFH following fracture healing. This subsequently progressed to cephalic screw cut-through and the development of an acetabular bone defect, necessitating total hip arthroplasty with acetabular augments. Among patients treated with cement augmented TFN-A, any new complaint of hip pain after fracture healing should prompt strong suspicion for ONFH and warrant thorough evaluation. Undue delay will progress ONFH and cause structural damage to acetabulum due to the exposed helical blade.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.